The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)
Abstract
About the Authors
O. D. OstroumovaRussian Federation
O. V. Bondarets
Russian Federation
T. F. Guseva
Russian Federation
References
1. Rothwell P.M, Howard S.C, Dolan E et al. Prognostic significance of visit - to - visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
2. Sever P.S, Dahlof B, Poulter N.R et al. Rationale, design, methods and baseline demography of participants of the Anglo- Scandinavian Cardiac Outcomes Trial. J Hypertens 2001; 6: 1139-47.
3. Dahlof B, Sever P.S, Poulter N.R et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentral randomized controlled trial. Lancet 2005; 366: 895-906.
4. Webb A.J.S, Fischer U, Mehta Z, Rothwell P.M. Effects of antihypertensive - drug class on interindividual variation in BP and risk of stroke: a systematic review and meta - analysis. Lancet 2010; 375: 906-15.
5. Rothwell P.M, Webb A.J.S. Effect of Dose and Combination of Antihypertensives on Interindividual Blood Pressure Variability: A Systematic Review. Stroke 2011; 42: 2860-5.
6. Диагностика и лечение артериальной гипертензии. Российский рекомендации (четвертый пересмотр). Системные гипертензии. 2010; 3: 5-26.
Review
For citations:
Ostroumova O.D., Bondarets O.V., Guseva T.F. The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»). Systemic Hypertension. 2014;11(1):11-16. (In Russ.)